\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ bilat\\ decreased\\ motor\\ strength\\,\\ otherwise\\ non\\-contributory\\.\ \(0\)\
\-\ inr\\ \\=\\ 1\\.0\ \(0\)\
\-\ wbc\\ \\=\\ 3\\.3\ \(0\)\
\-\ hct\\ \\=41\ \(0\)\
\-\ plt\\ \\=\\ 179\ \(0\)\
\-\ ast\\ \\=\\ 23\ \(0\)\
\-\ alt\\ \\=\\ 35\ \(0\)\
\-\ surgical\\ removal\ \(46\)\
\-\ an\\ extraaxial\\ lesion\\ is\\ seen\\ posteriorly\\ within\\ the\\ spinal\\ canal\\ from\\ the\\ level\\ of\\ t6\\ to\\ t9\\,\\ and\\ exits\\ the\\ neural\\ foramina\\ at\\ the\\ t7\\-t8\\ level\\ bilaterally\\.\\ this\\ lesion\\ presses\\ on\\ the\\ spinal\\ cord\\ and\\ demonstrates\\ isointense\\ t1\\ imaging\\ and\\ hyperintensity\\ on\\ t2\\ imaging\\,\\ with\\ uniform\\ enhancement\\ after\\ gadolinium\\ administration\\.\ \(0\)\
\-\ angiolipoma\\,spine\ \(1\)\
\-\ neurofibroma\ \(78\)\
\-\ schwannoma\ \(67\)\
\-\ atypical\\ meningioma\ \(6\)\
\-\ sarcoid\ \(163\)\
\-\ angiolipoma\ \(2\)\
\-\ a\\ 43\\-year\\-old\\ man\\ with\\ gradual\\ onset\\ of\\ numbness\\ from\\ umbilicus\\ distally\\ into\\ bilateral\\ lower\\ extremities\\,\\ with\\ complaints\\ of\\ inability\\ to\\ run\\ or\\ climb\\ stairs\\ secondary\\ to\\ hip\\ flexure\\ weakness\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\=\\:\\ 0\\.18380266736394127\ \(0\)\
\-\ angiolipoma\\:\\ 0\\.12650665795571128\ \(0\)\
\-\ \\=41\\:\\ 0\\.07225834773743031\ \(0\)\
\-\ t7\\-t8\\:\\ 0\\.07225834773743031\ \(0\)\
\-\ presses\\:\\ 0\\.06657681347054552\ \(0\)\
\-\ climb\\:\\ 0\\.06325332897785564\ \(0\)\
\-\ 179\\:\\ 0\\.060895279203660724\ \(0\)\
\-\ 43\\-year\\-old\\:\\ 0\\.059066233701085234\ \(0\)\
\-\ t6\\:\\ 0\\.05521374493677592\ \(0\)\
\-\ exits\\:\\ 0\\.05521374493677592\ \(0\)\
\-\ bilat\\:\\ 0\\.05424831021828097\ \(0\)\
\-\ umbilicus\\:\\ 0\\.05123417267627017\ \(0\)\
\-\ t9\\:\\ 0\\.05062673028156754\ \(0\)\
\-\ spinal\\:\\ 0\\.050160265743927644\ \(0\)\
\-\ run\\:\\ 0\\.05006121494151056\ \(0\)\
\-\ 3\\.3\\:\\ 0\\.04903528754024822\ \(0\)\
\-\ gradual\\:\\ 0\\.04494519601468274\ \(0\)\
\-\ plt\\:\\ 0\\.0446575622457379\ \(0\)\
\-\ inr\\:\\ 0\\.04385067640300633\ \(0\)\
\-\ stairs\\:\\ 0\\.04385067640300633\ \(0\)\
\-\ 1\\.0\\:\\ 0\\.043598449692623095\ \(0\)\
\-\ extraaxial\\:\\ 0\\.04311615051210725\ \(0\)\
\-\ flexure\\:\\ 0\\.04311615051210725\ \(0\)\
\-\ foramina\\:\\ 0\\.04244206773967306\ \(0\)\
\-\ uniform\\:\\ 0\\.04105619618193589\ \(0\)\
\-\ distally\\:\\ 0\\.04105619618193589\ \(0\)\
\-\ level\\:\\ 0\\.04037522996142512\ \(0\)\
\-\ inability\\:\\ 0\\.04019258539785535\ \(0\)\
\-\ neurofibroma\\:\\ 0\\.038835909672629336\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.03856266032617366\ \(0\)\
\-\ hct\\:\\ 0\\.03804205863992509\ \(0\)\
\-\ ast\\:\\ 0\\.03804205863992509\ \(0\)\
\-\ alt\\:\\ 0\\.03804205863992509\ \(0\)\
\-\ sarcoid\\:\\ 0\\.03594017725510807\ \(0\)\
\-\ neural\\:\\ 0\\.03546624634618327\ \(0\)\
\-\ isointense\\:\\ 0\\.03442949104201015\ \(0\)\
\-\ numbness\\:\\ 0\\.03365564116929643\ \(0\)\
\-\ 23\\:\\ 0\\.03329449371196831\ \(0\)\
\-\ gadolinium\\:\\ 0\\.03322413515712084\ \(0\)\
\-\ posteriorly\\:\\ 0\\.033085204351270235\ \(0\)\
\-\ imaging\\:\\ 0\\.03282088236812464\ \(0\)\
\-\ 35\\:\\ 0\\.03223538115885351\ \(0\)\
\-\ schwannoma\\:\\ 0\\.03199068473959382\ \(0\)\
\-\ strength\\:\\ 0\\.03107899920590346\ \(0\)\
\-\ complaints\\:\\ 0\\.030406335656278014\ \(0\)\
\-\ atypical\\:\\ 0\\.03035680848860619\ \(0\)\
\-\ motor\\:\\ 0\\.02924995370332797\ \(0\)\
\-\ administration\\:\\ 0\\.029079182499206314\ \(0\)\
\-\ lesion\\:\\ 0\\.028533692229515652\ \(0\)\
\-\ hip\\:\\ 0\\.02790059321402835\ \(0\)\
\-\ canal\\:\\ 0\\.027827732989296822\ \(0\)\
\-\ removal\\:\\ 0\\.02761295944508351\ \(0\)\
\-\ extremities\\:\\ 0\\.02747284113885974\ \(0\)\
\-\ meningioma\\:\\ 0\\.026935158495533403\ \(0\)\
\-\ cord\\:\\ 0\\.026616179673814765\ \(0\)\
\-\ weakness\\:\\ 0\\.026013207811708072\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.025869149247597353\ \(0\)\
\-\ wbc\\:\\ 0\\.025533400414555835\ \(0\)\
\-\ otherwise\\:\\ 0\\.025158321585461847\ \(0\)\
\-\ spine\\:\\ 0\\.023066422508240557\ \(0\)\
\-\ bilaterally\\:\\ 0\\.023005780643638552\ \(0\)\
\-\ t1\\:\\ 0\\.022200783083805277\ \(0\)\
\-\ onset\\:\\ 0\\.022110010048566803\ \(0\)\
\-\ decreased\\:\\ 0\\.02082587215348\ \(0\)\
\-\ from\\:\\ 0\\.020761241199249384\ \(0\)\
\-\ t2\\:\\ 0\\.019824498104511083\ \(0\)\
\-\ secondary\\:\\ 0\\.01958221284023613\ \(0\)\
\-\ enhancement\\:\\ 0\\.018774498082975707\ \(0\)\
\-\ mild\\:\\ 0\\.018444700442058502\ \(0\)\
\-\ bilateral\\:\\ 0\\.016998505977987247\ \(0\)\
\-\ into\\:\\ 0\\.01666660957344022\ \(0\)\
\-\ man\\:\\ 0\\.016565015107295075\ \(0\)\
\-\ lower\\:\\ 0\\.015752967781671005\ \(0\)\
\-\ demonstrates\\:\\ 0\\.015300173784042508\ \(0\)\
\-\ surgical\\:\\ 0\\.014723129264356177\ \(0\)\
\-\ after\\:\\ 0\\.014491813136141004\ \(0\)\
\-\ seen\\:\\ 0\\.013841209959571232\ \(0\)\
\-\ within\\:\\ 0\\.01336173285562362\ \(0\)\
\-\ on\\:\\ 0\\.011867065776482428\ \(0\)\
\-\ \\,\\:\\ 0\\.011094674816282268\ \(0\)\
\-\ to\\:\\ 0\\.010501674797778351\ \(0\)\
\-\ an\\:\\ 0\\.009685777576104343\ \(0\)\
\-\ at\\:\\ 0\\.009489861908456009\ \(0\)\
\-\ or\\:\\ 0\\.008209202860358259\ \(0\)\
\-\ this\\:\\ 0\\.007878173879624042\ \(0\)\
\-\ the\\:\\ 0\\.005665954291132204\ \(0\)\
\-\ is\\:\\ 0\\.004608940806432178\ \(0\)\
\-\ and\\:\\ 0\\.004426450960628323\ \(0\)\
\-\ a\\:\\ 0\\.0032508180476934533\ \(0\)\
\-\ with\\:\\ 0\\.002877151871062862\ \(0\)\
\-\ of\\:\\ 0\\.002864847560606273\ \(0\)\
\-\ \\.\\:\\ 0\\.0011639192163064352\ \(0\)\
